Brickell Biotech Stock Price To Sales
| BBIDelisted Stock | USD 1.79 0.34 23.45% |
Brickell Biotech fundamentals help investors to digest information that contributes to Brickell Biotech's financial success or failures. It also enables traders to predict the movement of Brickell Stock. The fundamental analysis module provides a way to measure Brickell Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Brickell Biotech stock.
Brickell |
Brickell Biotech Company Price To Sales Analysis
Brickell Biotech's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Brickell Biotech Price To Sales | 1.45 X |
Most of Brickell Biotech's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Brickell Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
CompetitionBased on the latest financial disclosure, Brickell Biotech has a Price To Sales of 1.4546 times. This is 93.2% lower than that of the Biotechnology sector and 98.52% lower than that of the Health Care industry. The price to sales for all United States stocks is 87.26% higher than that of the company.
Brickell Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Brickell Biotech's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Brickell Biotech could also be used in its relative valuation, which is a method of valuing Brickell Biotech by comparing valuation metrics of similar companies.Brickell Biotech is currently under evaluation in price to sales category among its peers.
Brickell Fundamentals
| Return On Equity | -1.57 | |||
| Return On Asset | -0.8 | |||
| Operating Margin | (6.58) % | |||
| Current Valuation | (8.35 M) | |||
| Shares Outstanding | 2.87 M | |||
| Shares Owned By Insiders | 1.20 % | |||
| Shares Owned By Institutions | 13.07 % | |||
| Number Of Shares Shorted | 189.59 K | |||
| Price To Earning | (35.16) X | |||
| Price To Book | 0.41 X | |||
| Price To Sales | 1.45 X | |||
| Revenue | 404 K | |||
| Gross Profit | (27.83 M) | |||
| EBITDA | (39.38 M) | |||
| Net Income | (39.47 M) | |||
| Cash And Equivalents | 17.29 M | |||
| Cash Per Share | 6.52 X | |||
| Total Debt | 69 K | |||
| Debt To Equity | 0 % | |||
| Current Ratio | 4.36 X | |||
| Book Value Per Share | 5.81 X | |||
| Cash Flow From Operations | (36.15 M) | |||
| Short Ratio | 0.62 X | |||
| Earnings Per Share | (0.42) X | |||
| Target Price | 17.83 | |||
| Number Of Employees | 16 | |||
| Beta | 0.0796 | |||
| Market Capitalization | 6.75 M | |||
| Total Asset | 29.72 M | |||
| Retained Earnings | (145.37 M) | |||
| Working Capital | 24.79 M | |||
| Current Asset | 52.66 M | |||
| Current Liabilities | 5.61 M | |||
| Net Asset | 29.72 M |
About Brickell Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Brickell Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Brickell Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Brickell Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in Brickell Stock
If you are still planning to invest in Brickell Biotech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Brickell Biotech's history and understand the potential risks before investing.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |